BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 32425365)

  • 21. Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.
    Fleming AB; Raabe V
    J Clin Virol; 2020 Jun; 127():104388. PubMed ID: 32361326
    [No Abstract]   [Full Text] [Related]  

  • 22. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma.
    Mira E; Yarce OA; Ortega C; Fernández S; Pascual NM; Gómez C; Alvarez MA; Molina IJ; Lama R; Santamaria M
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2793-2795. PubMed ID: 32652231
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of convalescent plasma in COVID-19 patients in China.
    Zhu M; Hu K; Zhu Z
    Transfus Clin Biol; 2020 Aug; 27(3):168-169. PubMed ID: 32425645
    [No Abstract]   [Full Text] [Related]  

  • 24. Convalescent plasma for patients with COVID-19.
    Zeng F; Chen X; Deng G
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12528. PubMed ID: 32398379
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
    Farrugia A
    Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
    [No Abstract]   [Full Text] [Related]  

  • 26. Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19.
    Rubin R
    JAMA; 2020 Jun; 323(21):2114-2117. PubMed ID: 32352484
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The convalescent sera option for containing COVID-19.
    Casadevall A; Pirofski LA
    J Clin Invest; 2020 Apr; 130(4):1545-1548. PubMed ID: 32167489
    [No Abstract]   [Full Text] [Related]  

  • 29. A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals.
    Casadevall A; Joyner MJ; Pirofski LA
    JAMA; 2020 Aug; 324(5):455-457. PubMed ID: 32492105
    [No Abstract]   [Full Text] [Related]  

  • 30. Convalescent plasma as a potential therapy for COVID-19.
    Chen L; Xiong J; Bao L; Shi Y
    Lancet Infect Dis; 2020 Apr; 20(4):398-400. PubMed ID: 32113510
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.
    Luetkens T; Metcalf R; Planelles V; Zheng Y; Larragoite ET; Spivak ES; Spivak AM; Steinbach M; Blaylock RC; Avila SV; Hankey KG; Martins TB; Slev PR; Mannuel HD; Sajadi M; Rapoport AP; Atanackovic D
    Blood Adv; 2020 Oct; 4(19):4864-4868. PubMed ID: 33031540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19.
    Kesici S; Yavuz S; Bayrakci B
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12526-12527. PubMed ID: 32398378
    [No Abstract]   [Full Text] [Related]  

  • 33. [A patient with severe COVID-19 treated with convalescent plasma].
    Hahn M; Condori MEH; Totland A; Kristoffersen EK; Hervig TA
    Tidsskr Nor Laegeforen; 2020 Sep; 140(12):. PubMed ID: 32900176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Convalescent serum lines up as first-choice treatment for coronavirus.
    Sheridan C
    Nat Biotechnol; 2020 Jun; 38(6):655-658. PubMed ID: 32358594
    [No Abstract]   [Full Text] [Related]  

  • 35. Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.
    Morabito CJ; Gangadharan B
    Clin Transl Sci; 2020 Sep; 13(5):835-837. PubMed ID: 32420691
    [No Abstract]   [Full Text] [Related]  

  • 36. Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19.
    Alzoughool F; Alanagreh L
    Int J Risk Saf Med; 2020; 31(2):47-51. PubMed ID: 32310190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 convalescent plasma donor recruitment: beware the Faustian bargains.
    Gniadek TJ; Donnersberger D
    Transfusion; 2020 Jul; 60(7):1643-1644. PubMed ID: 32428966
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma Therapies and Parabiosis in the COVID-19 Era.
    Calvani R; Picca A; Landi F; Marzetti E
    J Am Med Dir Assoc; 2020 Jul; 21(7):994-995. PubMed ID: 32674834
    [No Abstract]   [Full Text] [Related]  

  • 39. Convalescent plasma for COVID-19: the risk of pulmonary embolism should not be underestimated!
    Sanfilippo F; La Rosa V; Oliveri F; Astuto M
    Crit Care; 2020 Aug; 24(1):531. PubMed ID: 32859242
    [No Abstract]   [Full Text] [Related]  

  • 40. Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma.
    Jin H; Reed JC; Liu STH; Ho HE; Lopes JP; Ramsey NB; Waqar O; Rahman F; Aberg JA; Bouvier NM; Cunningham-Rundles C;
    J Allergy Clin Immunol Pract; 2020; 8(10):3594-3596.e3. PubMed ID: 32947026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.